Skip to content

An Ophthalmic Surgical Knives study to assess clinical performance and safety in patients undergoing cataract surgery.

Prospective, post-marketing, comparative, randomized, parallel, single blind clinical study of two Ophthalmic Surgical Knives to assess clinical performance and safety in patients undergoing cataract surgery.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/08/044920
Enrollment
154
Registered
2022-08-25
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H251- Age-related nuclear cataract

Interventions

Intervention1: Model â?? B0762262 - Clear Cornea - Single bevel- Bevel Up: Class B device, Polycarbonate and Stainless Steel Grade- SS 420 diameter 2.2mm Control Intervention1: Model â?? AA562022 - An

Sponsors

None
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age 18 year or greater 2. Cataract of any kind 3. Patient willing to participate and sign informed consent to participate in study and to use device related data for scientific purpose 4. Patient willing to come for all post-operative follow-up 5. Female participants of child bearing potential and male participants whose partner is of child bearing potential must be willing to ensure that they or their partner use effective contraception during the study

Exclusion criteria

Exclusion criteria: 1. Received (or is planning to receive) anti-coagulation, anti-platelet, or thrombolytic medications (e.g., warfarin), anti-inflammatory drugs [oral/ injectable corticosteroids or Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)], or other substances known to increase coagulation time from 10 days pre- to 3 days post injection 2. Traumatic cataract 3. Pregnancy (as stated by patient) or lactation 4. Concurrent participation in another drug or device investigation. 5. Patient receiving chloroquine treatment 6. Subjects with any systemic and metabolic disease that could increase operative risk or confound the outcome 7. Active ocular disease in the operative eye other than cataract 8. Vulnerable subjects 9. Patient having Microphthalmia 10. Patient having chronic uveitis 11. Patient suffering from Corneal dystrophy or endothelial insufficiency 12. Patient having active ocular diseases (active diabetic retinopathy, uncontrolled glaucoma) 13. Current participation or participation within 30 days prior to the start of this study in a drug or other investigational research study 14. Patient who sensitive or allergic to metals

Design outcomes

Primary

MeasureTime frame
The mean performance of both ophthalmic knives will be evaluated by overall surgeon satisfaction score in terms of following parameters [Time Frame: Intra-Operative] The sharpness of blade, ease of handling the blade, smoothness of incision creation, control while creating the wound.Timepoint: Intra-Operative, Post-Operative day 1 & day 30.

Secondary

MeasureTime frame
1) Wound integrity 2) Incision size accuracy 3) Astigmatism: Measurement by Pentacam. Following parameter will be measured - K1, K2 & K mean. Timepoint: Intra-Operative, Post-Operative day 1 & day 30.

Countries

India

Contacts

Public ContactProf A Heber

Dr. Agarwals Eye Hospital

drlionalraj@dragarwal.com8754411261

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026